Nader Z. Pourhassan, PhD, the former CEO of CytoDyn, was sentenced yesterday to 30 months in prison, more than a year after he was convicted on charges that included four counts of securities fraud, ...
With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.
AI‑driven protein design creates potent anti‑CRISPR inhibitors that block Cas13 activity, offering a new potential tool for safer, more controlled gene editing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results